Release Date: 23/05/16 17:04 Summary: Final Director's Interest Notice-SKI.AX Price Sensitive: No Download Document 60.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%